SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Coya Therapeutics Inc

Fueled by promising trial results and a strategic partnership with Dr. Reddy's, Coya is trending as the community focuses on its potential to disrupt the neurodegenerative disease space. Discussions revolve around the upcoming Alzheimer's data and the ALS trial, with many speculating about a potential acquisition. The company's novel approach and strong financial position are also driving bullish sentiment.

Targa Resources Corp. engages in the business of gathering, compressing, treating, processing, transporting, and purchasing and selling natural gas. It operates through the following segments: Gathering and Processing, and Logistics and Transportation, and Other. The Gathering and Processing segment includes assets used in the gathering, and purchase and sale of natural gas produced from oil and gas wells. The Logistics and Transportation segment refers to the activities and assets necessary to convert mixed natural gas liquids (NGLs) into NGL products. The Other contains the results of commodity derivative activity mark-to-market gains and losses related to derivative contracts. The company was founded on October 27, 2005 and is headquartered in Houston, TX.

Targa Resources Corp

Targa Resources is trending due to its upcoming inclusion in the S&P 500, replacing Nielsen Holdings. The community is discussing the implications of this move and the company's overall strength in the energy sector. Bullish sentiment is fueled by analyst ratings and potential benefits from increased natural gas demand and strategic positioning in the Permian Basin.

Dynex Capital, Inc. is an internally managed mortgage real estate investment trust. It engages in the business of investing in mortgage-backed securities. The company was founded on December 18, 1987 and is headquartered in Glen Allen, VA.

Dynex Capital, Inc.

Dynex Capital is trending as investors discuss its attractive monthly dividend and potential entry points, with some weighing it against similar REITs. Community members are highlighting the company's consistent dividend payments and solid management team. Broader market volatility and interest rate trends appear to be influencing discussions around DX.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending as the community debates recent price action and potential catalysts for future growth. Some traders are pointing to technical indicators suggesting a buying opportunity, while others express concern over governance issues and comparisons to competitors. Discussions also revolve around the broader market impact on Compound's performance.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

MOS is trending due to a recent announcement regarding production interruptions in potash and phosphate, impacting sales volume guidance and spurring community discussion around its effect on the stock. Despite the negative news, some investors view the dip as a buying opportunity, citing the company's strong underlying fundamentals, value, and dividend. Community members also mentioned the potential for long-term gains and a possible rotation into the agriculture sector.

Function is building the financial infrastructure that makes Bitcoin productive, unlocking yield, liquidity, and capital efficiency for holders across DeFi and traditional finance. FBTC turns Bitcoin into an asset that works.  FBTC represents the first omnichain Bitcoin yield asset, enabling BTC holders to participate in structured, risk-managed and programmatic yield strategies. FBTC is fully backed on a 1:1 basis with BTC, Bitcoin Reserve Address List is public and can be verified at any time. FBTC combines the security of Bitcoin reserves with the flexibility of smart contracts, creating a secure and efficient bridge between the Bitcoin network and modern DeFi protocols.  FBTC turns idle BTC into a functional and productive asset. The primary purpose of FBTC is to bring native Bitcoin liquidity into DeFi. Enabling Bitcoin holders to access a wide range of yield generating strategies, without having to sell their BTC. This not only enhances the utility of BTC but also allows holders to earn returns on their assets, making FBTC a powerful tool for maximizing the potential of Bitcoin in the DeFi ecosystem

Function ƒBTC

Function BTC ($FBTC) is trending as the community discusses recent ETF outflows and potential market pullbacks affecting Bitcoin. Optimists view any dip as a buying opportunity, drawing parallels to past recoveries of major tech stocks, while others express concern about macro factors and potential bear cycles. Community members are weighing the impact of potential rate cuts, crypto bills, and the possibility of a Santa Claus rally.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is trending due to positive Phase 3 acne trial results, sparking community excitement about its potential in the Chinese market and a new mechanism of action. Community members are actively discussing the undervaluation of the stock, potential buyout scenarios, and upcoming catalysts including the KOL event next week. Some are concerned about the absence of news on the mash program and the need for a funding partner.

Direxion Shares ETF Trust - Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

The Direxion Daily Homebuilders & Supplies Bull 3X Shares ($NAIL) is trending as traders discuss potential entry points based on technical indicators like falling wedge patterns and RSI levels, while some express hesitancy to invest. Community members are also weighing the ETF's outlook against broader market factors, including interest rate cut expectations and housing market data. Bullish sentiment anticipates momentum to continue into the spring, while bearish viewpoints cite concerns about a potential dip into the $30s over the winter.

Blockchain-on-Blockchain (BOB) is a new blockchain built on top of another blockchain called ICP. It's like a special layer on an existing system. BOB creates a secure digital record book that uses ICP's network for safety. BOB uses a system called 'proof-of-on-chain-work': You deploy your own smart contract (canister) at bob.fun. This program solves math problems (hashes). Main computers (mother nodes) give out these problems. Miners solve the problems and tell the mother node. If correct, the mother node adds a new block to the blockchain. The winning miner gets BOB tokens as a reward.

BOB is trending as community members highlight its potential as the "new BTC" and its association with the ICP ecosystem, with some suggesting it could outperform ICP. Community discussions also revolve around upcoming halving events and its listing on new platforms like Coinbase, increasing public awareness.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as investors assess its potential in the AI-driven data cloud sector, particularly after recent partnerships and analyst upgrades. Community discussions revolve around its long-term growth prospects and ability to maintain its competitive edge against major players. Bullish sentiment seems to be building around the stock's technical setup and potential for further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TransMedics Group (NASDAQ:TMDX) Insider Sells 3,000 Shares

TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) insider Anil Ranganath sold 3,000 shares of the company's stock in a transaction on Tuesday, November 25th. The stock was sold at an average...

TransMedics Group (NASDAQ:TMDX) Insider Anil Ranganath Sells 3,000 Shares

TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) insider Anil Ranganath sold 3,000 shares of the business's stock in a transaction that occurred on Tuesday, November 25th. The shares were sold...

DNB Asset Management AS Cuts Stake in TransMedics Group, Inc. $TMDX

DNB Asset Management AS cut its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 78.9% in the 2nd quarter, according to its most recent disclosure with the Securities and...

TransMedics Group (NASDAQ:TMDX) Sets New 12-Month High - Here's What Happened

TransMedics Group (NASDAQ:TMDX) Hits New 12-Month High - What's Next...

TransMedics Group, Inc. $TMDX Shares Sold by Bullseye Asset Management LLC

Bullseye Asset Management LLC decreased its position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 49.6% during the second quarter, according to the company in its most recent disclosure...

TransMedics Group (NASDAQ:TMDX) Shares Up 8.8% - Still a Buy?

TransMedics Group (NASDAQ:TMDX) Shares Up 8.8% - Here's What Happened...

TransMedics (TMDX) Just Overtook the 20-Day Moving Average

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

TransMedics (TMDX) Crossed Above the 50-Day Moving Average: What That Means for Investors

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

TransMedics (TMDX) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

5,577 Shares in TransMedics Group, Inc. $TMDX Acquired by Intrust Bank NA

Intrust Bank NA acquired a new stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Transmedics Group Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Stocktwits

Stocktwits Polls

Transmedics (TMDX) is trending as the stock approaches its 52-week high, fueled by community excitement around potential short squeezes and recent insider buying by the CEO.  Bullish sentiment is growing due to expectations of strong earnings and positive trial results, as well as potential expansion into Europe. Discussions also highlight the company's unique position in organ transplant technology and its potential for long-term growth.

TMDX
Transmedics Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TMDX News

TMDXTransmedics Group Inc